overactive%20bladder
OVERACTIVE BLADDER

Overactive bladder or non-neurogenic overactive bladder is a syndrome characterized by urinary urgency, frequency, nocturia and urgency incontinence.
It is not a disease but a symptom complex that generally is not a life-threatening condition. It is also known as bladder spasms.
Urgency is the complaint of sudden, compelling desire to pass urine that is difficult to deny. It is considered a hallmark symptom of overactive bladder.
Frequency is usually micturition of >7 episodes during waking hours.
Nocturia is the interruption of sleep one or more times because of the need to void.
Urgency incontinence is the involuntary leakage of urine associated with a sudden compelling desire to void.

Surgical Intervention

InterStim Therapy
  • Used in patients with urinary urgency, frequency, urge incontinence and retention
  • A small device implanted under the skin of one of the upper buttocks
  • Works by gently stimulating the sacral nerves to help the bladder function normally
Augmentation Cystoplasty
  • Small piece of tissue from the intestine is added to the wall of the bladder to increase the size of the bladder
  • Done by opening the abdomen and sometimes through the use of laparoscope
  • Consider in patients with non-progressive neurological disorders and impaired bladder storage
Urinary Diversion
  • Procedure is only done if all other options have failed to treat overactive bladder (OAB) symptoms
  • Tubes from the kidneys to the bladder and ureters are routed directly to the outside of your body
Nerve Stimulation
Sacral nerve stimulation
  • Small pulse generator is implanted under the skin of the buttock to send electrical signals to the nerves that control the bladder
Peroneal nerve stimulation
  • Another pulse generator used to stimulate the nerves controlling the bladder
Editor's Recommendations
Most Read Articles
09 Nov 2017
Treatment with fesoterodine shows efficacy in patients with nocturnal urgency secondary to overactive bladder syndrome and low nocturnal bladder capacity with a mismatch between nocturnal urine production and bladder capacity, reports a recent study.
14 Nov 2017
The 5-year survival rates for human papillomavirus (HPV)-associated cancers vary greatly according to age and race, with Caucasians and younger patients tending to have better survival, according to a recent US study.
01 Nov 2017
High-grade serous carcinomas (HGSCs) of the pelvis, whether associated with serous tubal intra-epithelial carcinoma lesions or not, appear to have shared biologic origin in the distal fallopian tube, according to a recent study.
28 Nov 2017
The use of oral androgen receptor inhibitor enzalutamide may benefit chemotherapy-naïve patients with metastatic castration-resistant prostate cancer and low baseline prostate specific antigen irrespective of disease burden, signifying that targeting the androgen receptor signalling pathway is a therapeutic option in similar patients, suggests a recent study.